Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer

被引：0
|
作者：
Andreas Varkaris
Anastasia Katsiampoura
Jennifer S. Davis
Neeraj Shah
Michael Lam
Rosa Lizeth Frias
Cristina Ivan
Masayoshi Shimizu
Jeffrey Morris
David Menter
Michael Overman
Hai Tran
John Heymach
Yun Shin Chun
Jean-Nicolas Vauthey
George Calin
Scott Kopetz
机构：
[1] Harvard Medical School,Department of Hematology Oncology, Beth Israel Deaconess Medical Center
[2] The University of Texas MD Anderson Cancer Center,Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine
[3] St. Elizabeth’s Medical Center,Department of Epidemiology, Division of Cancer Prevention and Population Sciences
[4] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics, Division of Basic Science Research
[5] The University of Texas MD Anderson Cancer Center,Department of Biostatistics, Division of Science
[6] The University of Texas MD Anderson Cancer Center,Department of Thoracic/Head and Neck Medical Oncology
[7] The University of Texas MD Anderson Cancer Center, Research, Division of Cancer Medicine
[8] The University of Texas MD Anderson Cancer Center,Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine
[9] The University of Texas MD Anderson Cancer Center,Hepato
来源：
British Journal of Cancer | 2019年 / 120卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：340 / 345
页数：5
相关论文
共 50 条
  • [1] Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
    Varkaris, Andreas
    Katsiampoura, Anastasia
    Davis, Jennifer S.
    Shah, Neeraj
    Lam, Michael
    Frias, Rosa Lizeth
    Ivan, Cristina
    Shimizu, Masayoshi
    Morris, Jeffrey
    Menter, David
    Overman, Michael
    Tran, Hai
    Heymach, John
    Chun, Yun Shin
    Vauthey, Jean-Nicolas
    Calin, George
    Kopetz, Scott
    BRITISH JOURNAL OF CANCER, 2019, 120 (03) : 340 - 345
  • [2] SIGNIFICANCE OF GENE AMPLIFICATIONS ON RELAPSE-FREE SURVIVAL (RFS) AND OVERALL SURVIVAL (OS) IN METASTATIC BREAST CANCER
    Todorovic-Rakovic, Natasa
    Neskovic-Konstantinovic, Zora
    Nikolic-Vukosavljevic, Dragica
    BREAST, 2013, 22 : S59 - S60
  • [3] Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer
    Martinez-Cardus, Anna
    Moran, Sebastian
    Musulen, Eva
    Moutinho, Catia
    Manzano, Jose L.
    Martinez-Balibrea, Eva
    Tierno, Montserrat
    Elez, Elena
    Landolfi, Stefania
    Lorden, Patricia
    Arribas, Carles
    Mueller, Fabian
    Bock, Christoph
    Tabernero, Josep
    Esteller, Manel
    GASTROENTEROLOGY, 2016, 151 (05) : 961 - 972
  • [4] A Prognostic Immunoscore for Relapse-Free Survival Prediction in Colorectal Cancer
    Wang, Haizhou
    Xu, Fei
    Zhang, Meng
    Liu, Jing
    Wang, Fan
    Zhao, Qiu
    DNA AND CELL BIOLOGY, 2020, 39 (07) : 1181 - 1193
  • [5] A TRIM24-like mutational signature predicts worse relapse-free survival (RFS) and overall survival (OS) in patients (pts) with metaplastic breast cancer (MpBC)
    Yam, Clinton
    Duncan, Aundrietta
    Chang, Jeffrey T.
    Gilcrease, Michael Z.
    Shah, Vrutant V.
    Barton, Michelle
    Moulder, Stacy L.
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
    Li, Yuanfang
    Yuan, Shuqiang
    Chen, Yingbo
    Nie, Man
    Li, Jibin
    Chen, Guoming
    Chen, Xiaojiang
    Zhang, Ruopeng
    Zheng, Ziqi
    Wei, Chengzhi
    Zhou, Zhiwei
    Nie, Runcong
    Wang, Yun
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (09): : 1085 - 1091
  • [7] Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival
    Maria Sayagues, Jose
    Carlos Montero, Juan
    Jimenez-Perez, Andrea
    del Carmen, Sofia
    Rodriguez, Marta
    Vidal Tocino, Rosario
    Montero, Enrique
    Sanz, Julia
    Abad, Mar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [8] Proteomic features of colorectal cancer independently predict relapse-free survival.
    Clarke, Callisia
    Lee, Michael Sangmin
    Manyam, Ganiraju C.
    Jiang, Zhi-Qin
    Tian, Feng
    Lu, Yiling
    Morris, Jeffrey
    Broom, Bradley McIntosh
    Menter, David
    Sanchez, Eduardo Vilar
    Raghav, Kanwal Pratap Singh
    Eng, Cathy
    Chang, George J.
    Overman, Michael J.
    Maru, Dipen M.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [9] A novel gene-pair signature for relapse-free survival prediction in colon cancer
    Chen, Peng-fei
    Wang, Fan
    Zhang, Zi-xiong
    Nie, Jia-yan
    Liu, Lan
    Feng, Jue-rong
    Zhou, Rui
    Wang, Hong-ling
    Liu, Jing
    Zhao, Qiu
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4145 - 4153
  • [10] A seven-gene signature predicts overall survival of patients with colorectal cancer
    Chen, Huarong
    Sun, Xiaoqiang
    Ge, Weiting
    Qian, Yun
    Bai, Rui
    Zheng, Shu
    ONCOTARGET, 2017, 8 (56) : 95054 - 95065
12345